Skip to main content
SpringerLink
Log in
Book cover

Treatment with Gallopamil

Results of recent research on calcium antagonism

  • Conference proceedings
  • © 1989

Overview

Editors:
  1. F. Bender

    1. Medizinische Universitätsklinik und Poliklinik, Münster, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. W. Meesmann

    1. Institut für Pathophysiologie, Universitätsklinikum Essen, Essen, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (19 papers)

  1. Front Matter

    Pages I-VIII
    Download chapter PDF

  2. Pharmacological aspects of calcium antagonism

    • H. A. Tritthart
    Pages 1-12

  3. Comparative effects of calcium antagonists and of inotropic agents on the development of hereditary cardiomyopathy in the hamster

    • G. Jasmin, L. Proschek
    Pages 13-24

  4. Haemorheological effects of gallopamil in angina pectoris — A controlled study

    • E. Ernst, A. Matrai
    Pages 25-28

  5. Effect of gallopamil on local excitability, conduction and the index of arrhythmogenicity in the early phase of acute myocardial ischaemia

    • M. Budden, W. Meesmann
    Pages 29-30

  6. Effects of gallopamil and nifedipine on ventricular arrhythmias, ventricular fibrillation, epicardial conduction delays and changes in the ventricular fibrillation threshold with time during myocardial ischaemia and reperfusion

    • W. Haverkamp, G. Hindricks, M. Kunert, J. Thale, Th. Behrenbeck, H. Gülker
    Pages 31-51

  7. Time courses of extracellular myocardial potassium activity during acute myocardial ischaemia and the effect of gallopamil in dogs and pigs

    • B. Vogt, M. Budden, M. Kirchengast, K. M. Zhang, C. Martin, W. Meesmann
    Pages 53-63

  8. New aspects on the pathophysiology of coronary heart disease

    • Gerd Heusch, B. D. Guth
    Pages 65-84

  9. The status of calcium antagonists in the drug treatment of coronary heart disease

    • Hartmut Gülker
    Pages 85-93

  10. Haemodynamic effects of gallopamil in patients with coronary heart disease and/or pulmonary hypertension

    • P. Richter, M. Stauch
    Pages 95-101

  11. The effect of gallopamil p.o. on global and regional ventricular function in patients with coronary heart disease

    • G. Großmann, M. Stauch, A. Schmidt, J. Waitzinger
    Pages 103-116

  12. Treatment of chronic stable angina pectoris with gallopamil

    • D. Scrutinio, S. Iliceto, R. Lagioia, D. Accettura, N. Preziusi, F. Mastropasqua et al.
    Pages 117-126

  13. Time course of the response to gallopamil in the steady State in the exercise ECG of patients with coronary heart disease

    • D. Fleischmann
    Pages 127-132

  14. Effects of gallopamil in patients with severe coronary heart disease: Investigations by radionuclide ventriculography

    • B. Brisse, M. Weber, F. Bender
    Pages 133-142

  15. Effects of intravenous and oral treatment with calcium antagonists on myocardial microperfusion

    • H. Eichstädt, O. Danne, H. P. Koch, M. Langer, M. Cordes, C. Schubert et al.
    Pages 143-150

  16. Incidence and importance of silent myocardial ischaemia — treatment with gallopamil

    • M. Zehender, T. Meinertz, A. Geibel, S. Hohnloser, C. Weiss, H. Just
    Pages 151-160

  17. Anti-anginal effect of gallopamil versus nifedipine

    • G. Rettig, S. Sen
    Pages 161-170

  18. Clinical and electrocardiographic effects of gallopamil and nifedipine in patients with coronary heart disease receiving basic treatment with ISDN

    • G. Bachour
    Pages 171-177

  19. Assessment of gallopamil (D 600) in patients with chronic stable angina pectoris Results of a placebo-controlled single-blind study

    • Guiseppe Specchia, F. Cobelli, L. Tavazzi, S. De Servi, M. Ferrario, S. Ghio et al.
    Pages 179-186

  20. Gallopamil and six other calcium antagonists in stable angina pectoris and a within-patient comparison of gallopamil with diltiazem

    • V. Bala Subramanian
    Pages 187-193
Back to top

Keywords

About this book

Calcium antagonists are currently the most extensively investigated drugs for the treatment of heart disease. They are used worldwide with great success and a comparatively low incidence of adverse reactions. The most prevalent and threatening diseases in modem industrialized societies - the various forms and complications of coronary arteriosclerosis and arterial hypertension - are amenable to treatment with calcium antagonists. The pharmacological spectrum of calcium antagonists is highly specific and was supplemen­ ted a few years ago by gallopamil, a verapamil analogue. The experimental work reported at this symposium was concerned with effects of gallopamil on the electrophysiology of the heart, particularly in acute myocardial ischemia. New therapeutic features of myocardial hypertrophy and hypertrophic cardiomyopathy are discussed. In medical practice, gallopa­ mil has proved particularly useful for the treatment of angina pectoris. Studies comparing gallopamil with other calcium antagonists are described to profile the properties of the drugs in terms of their specific therapeutic value. There is still a need for more differential therapeutic trials. This first international symposium on gallopamil was attended by experts from institutions devoted to theoretical and clinical research and general practice.

Editors and Affiliations

  • Medizinische Universitätsklinik und Poliklinik, Münster, Germany

    F. Bender

  • Institut für Pathophysiologie, Universitätsklinikum Essen, Essen, Germany

    W. Meesmann

Bibliographic Information

  • Book Title: Treatment with Gallopamil

  • Book Subtitle: Results of recent research on calcium antagonism

  • Editors: F. Bender, W. Meesmann

  • DOI: https://doi.org/10.1007/978-3-642-85376-0

  • Publisher: Steinkopff Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt 1989

  • Softcover ISBN: 978-3-642-85378-4Published: 16 December 2011

  • eBook ISBN: 978-3-642-85376-0Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: VIII, 194

  • Topics: Cardiology

Publish with us

Policies and ethics

Back to top

Search

Navigation